STOCK TITAN

Tourmaline Bio to Present at Upcoming Investor Conferences

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Tourmaline Bio (NASDAQ: TRML) has announced its participation in two upcoming investor conferences. Dr. Sandeep Kulkarni, Co-Founder and CEO, will participate in the Truist Securities BioPharma Symposium in New York on November 7, 2024, speaking on a panel about cardiac and skeletal muscle illnesses at 2:35 pm ET. He will also join a fireside chat at the Guggenheim Securities Healthcare Innovation Conference in Boston on November 12, 2024, at 1:30 pm ET.

Live webcasts and replays will be accessible through the company's investor relations website at ir.tourmalinebio.com under 'Events and Presentations.'

Loading...
Loading translation...
Argus Session date unavailable
-3.63% session move Open Argus
Details

News Market Reaction – TRML

The recorded move for TRML in the trading session of this news was -3.63%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients with life-altering immune and inflammatory diseases, today announced that Sandeep Kulkarni, MD, Co-Founder and Chief Executive Officer, is expected to participate in the following investor conferences:

Truist Securities BioPharma Symposium, New York
Panel: Close to Heart: Innovative Approaches to Targeting Cardiac & Skeletal Muscle Illnesses
Thursday, November 7, 2024 at 2:35 pm ET

Guggenheim Securities Healthcare Innovation Conference, Boston
Fireside Chat
Tuesday, November 12, 2024 at 1:30 pm ET

Live webcasts and replays, when available, will be available under "Events and Presentations" in the News & Investors section of the Tourmaline Bio website at ir.tourmalinebio.com.

For more information about Tourmaline Bio and pacibekitug, please visit https://www.tourmalinebio.com or follow us on LinkedIn or X.

About Tourmaline Bio
Tourmaline is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune and inflammatory diseases. Tourmaline’s lead asset is pacibekitug (also referred to as TOUR006).

Media Contact
Scient PR
Sarah Mishek
SMishek@ScientPR.com  

Investor Contact
Meru Advisors
Lee M. Stern
lstern@meruadvisors.com


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Tourmaline Bio (TRML) presenting at the Truist Securities BioPharma Symposium?

Tourmaline Bio is presenting at the Truist Securities BioPharma Symposium on Thursday, November 7, 2024, at 2:35 pm ET in New York.

What conferences is Tourmaline Bio (TRML) attending in November 2024?

Tourmaline Bio is attending the Truist Securities BioPharma Symposium in New York on November 7 and the Guggenheim Securities Healthcare Innovation Conference in Boston on November 12, 2024.

Where can investors watch Tourmaline Bio's (TRML) conference presentations?

Investors can access live webcasts and replays of the presentations through Tourmaline Bio's website at ir.tourmalinebio.com under the 'Events and Presentations' section.

Keep reading